Search Results - "CALO, L. A"

Refine Results
  1. 1
  2. 2
  3. 3

    Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter’s and Gitelman’s syndromes by Calò, L. A., Maiolino, G.

    Published in Journal of endocrinological investigation (01-07-2015)
    “…Introduction Extensive studies using Bartter’s/Gitelman’s syndrome patients have provided insights into the angiotensin II (Ang II) signaling pathways involved…”
    Get full text
    Journal Article
  4. 4

    Vascular tone control in humans: Insights from studies in Bartter's/Gitelman's syndromes by CALO, L. A

    Published in Kidney international (01-03-2006)
    “…Studies in patients with Bartter's and Gitelman's syndromes performed in the last 10 years have provided important insights into the mechanistic details of…”
    Get full text
    Journal Article
  5. 5

    Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes by Scognamiglio, R, Negut, C, Calò, L A

    Published in Clinical nephrology (01-03-2007)
    “…Sudden cardiac death (SCD) occurs in patients with Bartter/Gitelman syndromes. Hypokalemia and QTc prolongation are suggested mechanisms. SCD, however, has…”
    Get more information
    Journal Article
  6. 6

    Myocardial perfusion defects in Bartter and Gitelman syndromes by Scognamiglio, R., Calò, L. A., Negut, C., Coccato, M., Mormino, P., Pessina, A. C.

    Published in European journal of clinical investigation (01-12-2008)
    “…ABSTRACT Background  Normotensive hypokalaemic tubulopathies (Bartter and Gitelman syndromes (BS/GS)) are genetic diseases that are considered benign. However,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    A new approach to the evaluation of hyperphosphatemia in chronic kidney disease by Savica, V, Calò, L A, Granata, A, Caldarera, R, Cavaleri, A, Santoro, D, Monardo, P, Savica, R, Muraca, U, Bellinghieri, G

    Published in Clinical nephrology (01-10-2007)
    “…Hyperphosphoremia, main contributor to cardiovascular calcifications, has a major impact on the morbidity and mortality of chronic renal failure (CRF)…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension by Ravarotto, V., Simioni, F., Sabbadin, C., Pagnin, E., Maiolino, G., Armanini, D., Calò, L. A.

    Published in Journal of endocrinological investigation (01-05-2019)
    “…Purpose Aldosterone proinflammatory/profibrotic effects are mediated by the induction of mononuclear leucocytes (MNL) to express oxidative stress…”
    Get full text
    Journal Article
  19. 19

    Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program by D’Elia, L., Manfredi, M., Strazzullo, P., Galletti, F.

    Published in European journal of clinical nutrition (01-05-2019)
    “…Background/objectives The aim of the present study was to validate a short questionnaire on habitual dietary salt intake, to quickly and easily identify…”
    Get full text
    Journal Article
  20. 20

    Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension by Pagnin, E., Ravarotto, V., Maiolino, G., Naso, E., Davis, P. A., Calò, L. A.

    Published in Journal of endocrinological investigation (01-03-2018)
    “…Purpose Gitelman’s syndrome (GS) presents normo-hypotension and absence of cardiovascular–renal remodeling despite high angiotensin II (Ang II), activation of…”
    Get full text
    Journal Article